Search Results - "Lasocki, A"

  • Showing 1 - 18 results of 18
Refine Results
  1. 1

    Non-Contrast-Enhancing Tumor: A New Frontier in Glioblastoma Research by Lasocki, A, Gaillard, F

    Published in American journal of neuroradiology : AJNR (01-05-2019)
    “…There is a growing understanding of the prognostic importance of non-contrast-enhancing tumor in glioblastoma, and recent attempts at more aggressive…”
    Get full text
    Journal Article
  2. 2

    MRI Features Can Predict 1p/19q Status in Intracranial Gliomas by Lasocki, A, Gaillard, F, Gorelik, A, Gonzales, M

    Published in American journal of neuroradiology : AJNR (01-04-2018)
    “…The 2016 revision of the mandates codeletion of chromosomes 1p and 19q for the diagnosis of oligodendroglioma. We studied whether conventional MR imaging…”
    Get full text
    Journal Article
  3. 3

    Noninvasive Determination of IDH and 1p19q Status of Lower-grade Gliomas Using MRI Radiomics: A Systematic Review by Bhandari, A P, Liong, R, Koppen, J, Murthy, S V, Lasocki, A

    Published in American journal of neuroradiology : AJNR (01-01-2021)
    “…Determination of ( ) status and, if -mutant, assessing 1p19q codeletion are an important component of diagnosis of World Health Organization grades II/III or…”
    Get full text
    Journal Article
  4. 4

    Neuro-Oncology and Radiogenomics: Time to Integrate? by Lasocki, A, Rosenthal, M A, Roberts-Thomson, S J, Neal, A, Drummond, K J

    Published in American journal of neuroradiology : AJNR (01-11-2020)
    “…Radiogenomics aims to predict genetic markers based on imaging features. The critical importance of molecular markers in the diagnosis and management of…”
    Get full text
    Journal Article
  5. 5

    The imaging of immunotherapy-related hypophysitis and other pituitary lesions in oncology patients by Lasocki, A., Iravani, A., Galligan, A.

    Published in Clinical radiology (01-05-2021)
    “…Immunotherapy has revolutionised the treatment of metastatic disease from a variety of different primaries, but is frequently associated with immune-related…”
    Get full text
    Journal Article
  6. 6

    Central nervous system manifestations of systemic haematological malignancies and key differentials by Lasocki, A., Seymour, J.F.

    Published in Clinical radiology (01-05-2022)
    “…Central nervous system (CNS) involvement by haematological malignancies is uncommon, and generally associated with a poor prognosis. Neuroimaging plays a key…”
    Get full text
    Journal Article
  7. 7

    MRI grading versus histology: predicting survival of World Health Organization grade II-IV astrocytomas by Lasocki, A, Tsui, A, Tacey, M A, Drummond, K J, Field, K M, Gaillard, F

    Published in American journal of neuroradiology : AJNR (01-01-2015)
    “…Histologic grading of intracranial astrocytomas is affected by sampling error and substantial inter- and intraobserver variability. We proposed that…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Intracranial involvement by multiple myeloma by Lasocki, A, Gangatharan, S, Gaillard, F, Harrison, S.J

    Published in Clinical radiology (01-08-2015)
    “…Intracranial involvement is a rare complication of multiple myeloma. It results either from direct extra-osseous spread from adjacent skeletal plasmacytomas or…”
    Get full text
    Journal Article
  10. 10

    Memory loss and confusion by Lasocki, A.

    Published in Journal of clinical neuroscience (01-12-2019)
    “…•FLAIR hyperintensity affecting the limbic system has a range of differentials.•Small cell lung carcinoma is the most common cause of paraneoplastic limbic…”
    Get full text
    Journal Article
  11. 11

    Memory loss and confusion: Answer by Lasocki, A.

    Published in Journal of clinical neuroscience (01-12-2019)
    “…•FLAIR hyperintensity affecting the limbic system has a range of differentials.•Small cell lung carcinoma is the most common cause of paraneoplastic limbic…”
    Get full text
    Journal Article
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16

    P05.02.A PRELIMINARY FINDINGS FROM THE MRI QUALITY ASSURANCE PROGRAMME FOR THE PROSPECTIVE MULTI-SITE AUSTRALIAN FIG ([FET-PET IN GLIOBLASTOMA) TROG 18.06 STUDY by Brighi, C, Moffat, B A, Whitehead, A, Cook, O, Moore, A, Grose, A, Rossi, A, Dykyj, R, Lau, E, Fitt, G, Lasocki, A, Gan, H K, Scott, A M, Koh, E

    Published in Neuro-oncology (Charlottesville, Va.) (08-09-2023)
    “…Abstract BACKGROUND The O-(2-[18F]-fluoroethyl)-L-tyrosine positron emission tomography (FET-PET) in Glioblastoma (FIG) study is a prospective study evaluating…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Determination of the Self-Excite Vibration Amplitude of a Rigid Rotor Supported on n-lobe Journal Bearing by Lasocki, A., Starczewski, Z.

    “…In this paper possibilities of impacting on self‐excited threshold and on amplitude of arisen self‐excited vibrations are investigated. The short symmetrical…”
    Get full text
    Journal Article